Congenital Disorders of Glycosylation
Gene: ALG1
Neuroimaging abnormalities cerebellar or cerebral atrophy
Usually abnormal transferrin isoelectric focussing
Protein-linked xeno-tetrasaccharide biomarker, NeuAc-Gal-GlcNAc2
Often missense variantsCreated: 26 Aug 2020, 11:14 a.m. | Last Modified: 26 Aug 2020, 11:14 a.m.
Panel Version: 0.151
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
Developmental delay; Intellectual disability; Hypotonia; Seizure/Epilepsy; Visual Involvement; Microcephaly; Abnormal Brain Imaging; Facial Dysmorphism; Haematological; Gastrointestinal; Skeletal Abnormalities, Hypoalbuminaemia; Recurrent infections; Liver dysfunction; Cardiac Abnormalities, Renal Abnormalities
Publications
Variants in this GENE are reported as part of current diagnostic practice
Gene: alg1 has been classified as Green List (High Evidence).
Phenotypes for gene: ALG1 were changed from to Congenital disorder of glycosylation, type Ik 608540
Publications for gene: ALG1 were set to
Mode of inheritance for gene: ALG1 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal
gene: ALG1 was added gene: ALG1 was added to Congenital Disorders of Glycosylation_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services Mode of inheritance for gene: ALG1 was set to Unknown